Biomarin Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOMARIN PHARM, and what generic alternatives to BIOMARIN PHARM drugs are available?
BIOMARIN PHARM has three approved drugs.
There are fourteen US patents protecting BIOMARIN PHARM drugs.
There are one hundred and fifty-five patent family members on BIOMARIN PHARM drugs in thirty countries and nine supplementary protection certificates in nine countries.
Summary for Biomarin Pharm
| International Patents: | 155 |
| US Patents: | 14 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 3 |
| Patent Litigation for Biomarin Pharm: | See patent lawsuits for Biomarin Pharm |
Drugs and US Patents for Biomarin Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | AB | RX | Yes | Yes | 7,566,462*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
| Biomarin Pharm | VOXZOGO | vosoritide | POWDER;SUBCUTANEOUS | 214938-001 | Nov 19, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | AB | RX | Yes | Yes | 7,566,714*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
| Biomarin Pharm | VOXZOGO | vosoritide | POWDER;SUBCUTANEOUS | 214938-002 | Nov 19, 2021 | RX | Yes | Yes | RE48267 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BIOMARIN PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Powder for Oral Solution | 100 mg per packet | ➤ Subscribe | 2015-11-09 |
| ➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2014-05-30 |
| ➤ Subscribe | Powder for Oral Solution | 500 mg/packet | ➤ Subscribe | 2016-12-20 |
International Patents for Biomarin Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1139864 | ⤷ Try a Trial |
| Japan | 2012207029 | ⤷ Try a Trial |
| Hungary | E029533 | ⤷ Try a Trial |
| China | 1905863 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Biomarin Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2432489 | 2022C/503 | Belgium | ⤷ Try a Trial | PRODUCT NAME: VOSORITIDE SOUS TOUTES SES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/21/1577 20210901 |
| 2432489 | 122022000008 | Germany | ⤷ Try a Trial | PRODUCT NAME: VOSORITID IN ALLEN DURCH DAS GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/21/1577 20210826 |
| 2432489 | 301162 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: VOSORITIDE IN IEDERE VORM ZOALS BESCHERMD DOOR HET BASISOCTROOI; REGISTRATION NO/DATE: EU/1/21/1577 20210901 |
| 2432489 | 2290005-4 | Sweden | ⤷ Try a Trial | PRODUCT NAME: VOSORITIDE; REG. NO/DATE: EU/1/21/1577 20210921 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
